Helland, T., Naume, B., Hustad, S., Bifulco, E., Kvaløy, J. T., Sætersdal, A. B., . . . Søiland, H. (2020). Low Z‐4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen. Mol Oncol.
Chicago Style CitationHelland, Thomas, et al. "Low Z‐4OHtam Concentrations Are Associated With Adverse Clinical Outcome Among Early Stage Premenopausal Breast Cancer Patients Treated With Adjuvant Tamoxifen." Mol Oncol 2020.
MLA CitationHelland, Thomas, et al. "Low Z‐4OHtam Concentrations Are Associated With Adverse Clinical Outcome Among Early Stage Premenopausal Breast Cancer Patients Treated With Adjuvant Tamoxifen." Mol Oncol 2020.
Warning: These citations may not always be 100% accurate.